Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

NCT00393341 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00393341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00393341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
Lead sponsor
Indiana University
Phase
Observational
Overall status
Completed
Start date
October 31, 2006
Completion date
August 31, 2009
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage i, breast cancer stage ii, breast cancer stage iv